Zurcher Kantonalbank (Zurich Cantonalbank) Sutro Biopharma, Inc. Transaction History

Zurcher Kantonalbank (Zurich Cantonalbank)

$32.8 Billion
Q3 2024

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 30, 2024	SELL	$2.07 - $4.54 $3,856 - $8,458	-1,863 Reduced 86.73%	285 $1,000
Q3 2023 Oct 25, 2023	SELL	$3.29 - $4.9 $1,125 - $1,675	-342 Reduced 13.73%	2,148 $7,000
Q2 2023 Aug 07, 2023	SELL	$4.25 - $5.88 $2,779 - $3,845	-654 Reduced 20.8%	2,490 $11,000
Q1 2023 May 08, 2023	BUY	$4.48 - $8.45 $14,085 - $26,566	3,144 New	3,144 $14,000
Q2 2022 Aug 09, 2022	SELL	$3.41 - $8.95 $29,803 - $78,223	-8,740 Closed	0 $0
Q1 2022 Apr 21, 2022	BUY	$7.78 - $15.31 $48,640 - $95,718	6,252 Added 251.29%	8,740 $72,000
Q4 2021 Feb 01, 2022	SELL	$14.25 - $23.53 $3,605 - $5,953	-253 Reduced 9.23%	2,488 $37,000
Q3 2021 Nov 15, 2021	BUY	$16.88 - $22.38 $1,130 - $1,499	67 Added 2.51%	2,741 $52,000
Q2 2021 Jul 30, 2021	BUY	$18.03 - $23.82 $1,839 - $2,429	102 Added 3.97%	2,674 $50,000
Q1 2021 May 03, 2021	BUY	$20.29 - $27.54 $52,185 - $70,832	2,572 New	2,572 $59,000

Others Institutions Holding STRO

# of Institutions

140

Shares Held

62.4M

Call Options Held

77.1K

Put Options Held

31.4K

Suvretta Capital Management, LLC New York, NY

7.19M
Shares

$14.7 Million
0.98% of portfolio
Black Rock Inc. New York, NY

6.91M
Shares

$14.1 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

4.2M
Shares

$8.56 Million
0.0% of portfolio
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct

3M
Shares

$6.11 Million
0.03% of portfolio
Bio Impact Capital LLC Cambridge, MA

2.83M
Shares

$5.78 Million
1.53% of portfolio

View Full List

About SUTRO BIOPHARMA, INC.

Ticker STRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,161,500
Market Cap $106M
Description
Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...

More about STRO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.

Account